VolitionRx teams up with leading French veterinary group to assess potential of cancer screening technology
The non-interventional study will be overseen by Dr Jérôme Benoit, the clinical director of Oncovet in Lille VolitionRx (NYSE-A:VNRX) Limited said it will work with a
16 novembre 2022